[1] 王呈,曾炳芳.骨移植替代材料在创伤骨科的应用[J]. 国际骨科学杂志, 2012, 33(1):37-38.
[2] Dalle Carbonare L, Innamorati G, Valenti MT. Transcription factor Runx2 and its application to bone tissue engineering[J]. Stem Cell Rev, 2012, 8(3):891-897.
[3] Liu TM, Lee EH. Transcriptional regulatory cascades in Runx2-dependent bone development[J].Tissue Eng Part B Rev, 2013,19(3):254-263.
[4] Lucero CM, Vega OA, Osorio MM, et al. The cancer-related transcription factor Runx2 modulates cell proliferation in human osteosarcoma cell lines[J]. J Cell Physiol, 2013, 228(4):714-723.
[4] Zou D, Zhang Z, He J, et al. Repairing critical-sized calvarial defects with BMSCs modified by a constitutively active form of hypoxia-inducible factor-1α and a phosphate cement scaffold[J]. Biomaterials, 2011, 32(36):9707-9018.
[5] Nery AA, Nascimento IC, Glaser T, et al. Human mesenchymal stem cells: from immunophenotyping by flow cytometry to clinical applications[J]. Cytometry A,2013,83(1):48-61.
[6] Fernández Vallone VB, Romaniuk MA, Choi H, et al. Mesenchymal stem cells and their use in therapy: What has been achieved[J]? Differentiation, 2013, 85(1-2):1-10.
[7] Wang GP, Levine BL, Binder GK, et a1. Analysis of lentiviral vector integration in HIV+ study subjects receiving autologous infusions of gene modified CD4+ T cells[J]. Mol Ther, 2009, 17(5):844-850.
[8] Matrai J, Chuah MK, Vanden Driessche T. Recent advances in lentiviral vector development and applications[J]. Mol Ther, 2010,18(3):477-490.
[9] Marie PJ, Fromigue O. Osteogenic differentiation of human marrow-derived mesenchymal stem cells[J]. Regen Med, 2006, 1(4):539-548.
[10]廖庆辉, 黄震, 蔡德鸿. 抗坏血酸、甘油磷酸钠和地塞米松联合诱导大鼠骨髓间充质干细胞向成骨细胞的分化[J].中国组织工程研究与临床康复,2009,13(1):88-91.
[11] Scheller EL, Krebsbach PH, Kohn DH. Tissue engineering: state of the art in oral rehabilitation[J]. J Oral Rehabil, 2009, 36(5):368-389. |